United States: The Drug Price Negotiation Program Faces Pushback From Private And Public Industry Participants - Sheppard Mullin Richter & Hampton
This month, pharmaceutical manufacturer, Merck & Co., Inc. ("Merck"), as well as four chambers of commerce, have filed suits against the federal government...
Full Article